EUVIMEDEUVIMED entdecken
Crossref

Therapeutic potential of a polyherbal extract against COVID-19 and associated inflammation and mucormycosis: In vitro characterization and in vivo validation in a human coronavirus 229E–infected mouse model

Shrikant S Magdum, John I Disouza, Arehalli S Manjappa, Sunil T Galatage

Annales Pharmaceutiques Françaises · 2026-06 · 84 (4) · 662-685

DOI: 10.1016/j.pharma.2026.01.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annales Pharmaceutiques Françaises, 2026-06. Verfasst von Shrikant S Magdum und 3 weiteren Autor:innen. Beteiligte Einrichtung: Tatyasaheb Kore College of Pharmacy, Warananagar 416113, Maharashtra, India; Department of Pharmaceutics, Appasaheb Birnale College of Pharmacy, Sang…. Hauptthemen laut MEDLINE: Mucormycosis, Plant Extracts, Anti-Inflammatory Agents, Antiviral Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 97 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rise of viral infections has been accompanied by an increased incidence of secondary opportunistic infections, such as mucormycosis, highlighting the urgent need for broad-spectrum therapeutics capable of targeting multiple pathological pathways. This study evaluates the antiviral, antioxidant, anti-inflammatory, and antifungal potential of a polyherbal extract (PHE) and its optimized self-nanoemulsifying intravenous formulation (PH-SNEDDS). PHE displayed strong free-radical-scavenging activity (DPPH, IC50: 21.99μg/mL; ABTS, IC50: 58.97μg/mL) and significantly downregulated pro-inflammatory mediators in LPS-stimulated THP-1 and RAW 264.7 cells, reducing TNF-α and iNOS gene expression by 4.04-fold and 4.91-fold, respectively. The extract also exhibited potent antifungal activity against Apophysomyces elegans (MIC: 1μg/mL) and Rhizopus oryzae (MIC: 0.5μg/mL). In A549 lung epithelial cells, PHE effectively inhibited HCoV-229E replication with minimal cytotoxicity. The PH-SNEDDS formulation demonstrated optimal physicochemical properties, including a particle size of 146±2.9nm and zeta potential of -41.1±2.7mV. In HCoV-229E-infected BALB/c mice, PH-SNEDDS significantly reduced pulmonary viral load, mitigated histopathological damage, and suppressed viral RNA and protein expression. Immunological profiling revealed a shift toward protective immune responses, with an increased Th1/Th2 ratio (1.37±0.06), decreased Th17/Treg ratio (1.97±0.08), and elevated B cell (3.31±0.18) and NK cell (2.57±0.08) populations, along with markedly lower serum levels of IL-6 (59.62±5.03pg/mL) and TNF-α (121.75±5.83pg/mL). Collectively, these findings demonstrate the strong antiviral, anti-inflammatory, and antifungal efficacy of PH-SNEDDS, supporting its potential as a promising multifunctional therapeutic candidate for coronavirus infections and their associated inflammatory or fungal complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MucormycosisPlant ExtractsAnti-Inflammatory AgentsAntiviral AgentsCOVID-19 Drug TreatmentInflammationAntifungal AgentsAnimalsHumansMiceDisease Models, AnimalSARS-CoV-2COVID-19RAW 264.7 CellsA549 CellsAntioxidantsFemale

Stichwörter der Autor:innen

Anti-inflammatoireAnti-inflammatoryCoronavirus humainHerbal medicinesHuman coronavirusIV-nanoemulsionMucormycoseMucormycosisNanoémulsion IVPhytothérapieRT-PCRRéplication viraleViral replication

Substanzen

Plant ExtractsAnti-Inflammatory AgentsAntiviral AgentsAntifungal AgentsAntioxidants

Autor:innen und Institutionen

  • Tatyasaheb Kore College of Pharmacy, Warananagar 416113, Maharashtra, India; Department of Pharmaceutics, Appasaheb Birnale College of Pharmacy, Sangli 416416, Maharashtra, India.
  • Tatyasaheb Kore College of Pharmacy, Warananagar 416113, Maharashtra, India; Department of Pharmaceutics, SYBES's Bombay Institute of Pharmacy & Research, Dombivli (East), Maharashtra, India. Electronic address: johnsir…
  • Department of Pharmaceutics, Vasantidevi Patil Institute of Pharmacy, Kodoli 416114, Kolhapur, Maharashtra, India. Electronic address: manju_as82@yahoo.co.in.
  • Department of Pharmaceutics, Vasantidevi Patil Institute of Pharmacy, Kodoli 416114, Kolhapur, Maharashtra, India.

Zitieren

APA

Magdum, S. S., Disouza, J. I., Manjappa, A. S., & Galatage, S. T. (2026). Therapeutic potential of a polyherbal extract against COVID-19 and associated inflammation and mucormycosis: In vitro characterization and in vivo validation in a human coronavirus 229E–infected mouse model. Annales Pharmaceutiques Françaises, 84(4), 662-685. https://doi.org/10.1016/j.pharma.2026.01.004

Vancouver

Magdum SS, Disouza JI, Manjappa AS, Galatage ST. Therapeutic potential of a polyherbal extract against COVID-19 and associated inflammation and mucormycosis: In vitro characterization and in vivo validation in a human coronavirus 229E–infected mouse model. Annales Pharmaceutiques Françaises. 2026;84(4):662-685. doi:10.1016/j.pharma.2026.01.004

BibTeX
@article{Magdum2026,
  author = {Magdum, Shrikant S and Disouza, John I and Manjappa, Arehalli S and Galatage, Sunil T},
  title = {Therapeutic potential of a polyherbal extract against COVID-19 and associated inflammation and mucormycosis: In vitro characterization and in vivo validation in a human coronavirus 229E–infected mouse model},
  journal = {Annales Pharmaceutiques Françaises},
  year = {2026},
  volume = {84},
  number = {4},
  pages = {662--685},
  doi = {10.1016/j.pharma.2026.01.004}
}
Kostenlos starten →